Cardiovascular  	Cardiovascular  	 JJ	B-NP
magnetic  	magnetic  	 JJ	I-NP
resonance  	resonance  	 NN	I-NP
for  	for  	 IN	I-NP
amyloidosis  	amyloidosis  	 JJ	I-NP
Cardiac  	Cardiac  	 JJ	I-NP
involvement  	involvement  	 NN	I-NP
drives  	drives  	 VBZ	O
the  	the  	 DT	O
prognosis  	prognosis  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	O
in  	in  	 IN	O
systemic  	systemic  	 JJ	B-NP
amyloid 	amyloid 	 NN	I-NP
.  	.  	 .	O
Echocardiography 	Echocardiography 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
mainstay  	mainstay  	 NN	O
of  	of  	 IN	O
current  	current  	 JJ	O
cardiac  	cardiac  	 JJ	B-NP
imaging 	imaging 	 NN	I-NP
,  	,  	 ,	O
defines  	defines  	 VBZ	O
cardiac  	cardiac  	 JJ	B-NP
structure  	structure  	 NN	I-NP
and  	and  	 CC	O
function 	function 	 NN	O
.  	.  	 .	O
Echocardiography 	Echocardiography 	 NNP	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
conjunction  	conjunction  	 NN	O
with  	with  	 IN	O
clinical  	clinical  	 JJ	B-NP
phenotype 	phenotype 	 NN	I-NP
,  	,  	 ,	O
electrocardiogram  	electrocardiogram  	 NN	O
and  	and  	 CC	O
biomarkers  	biomarkers  	 NNS	B-NP
( 	( 	 -LRB-	O
brain  	brain  	 FW	B-NP
natriuretic  	natriuretic  	 FW	I-NP
peptide  	peptide  	 FW	I-NP
and  	and  	 CC	O
troponin 	troponin 	 CD	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
provides  	provides  	 VBZ	O
an  	an  	 DT	O
assessment  	assessment  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
likelihood  	likelihood  	 NN	O
and  	and  	 CC	O
extent  	extent  	 NN	O
of  	of  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
involvement 	involvement 	 NN	I-NP
.  	.  	 .	O
Two  	Two  	 CD	O
tests  	tests  	 NNS	O
are  	are  	 VBP	O
transforming  	transforming  	 VBG	O
our  	our  	 PRP$	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
amyloidosis 	amyloidosis 	 NN	I-NP
,  	,  	 ,	O
bone  	bone  	 FW	O
tracer  	tracer  	 FW	O
scanning  	scanning  	 FW	O
and  	and  	 CC	O
cardiovascular  	cardiovascular  	 JJ	B-NP
magnetic  	magnetic  	 JJ	I-NP
resonance  	resonance  	 NN	I-NP
( 	( 	 -LRB-	O
CMR 	CMR 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
CMR  	CMR  	 NNP	B-NP
provides  	provides  	 VBZ	O
a  	a  	 DT	O
second  	second  	 JJ	O
opinion  	opinion  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
heart 	heart 	 NN	O
's  	's  	 POS	O
structure  	structure  	 NN	O
and  	and  	 CC	O
systolic  	systolic  	 JJ	B-NP
function  	function  	 NN	I-NP
with  	with  	 IN	O
better  	better  	 JJR	O
accuracy  	accuracy  	 NN	B-NP
and  	and  	 CC	O
more  	more  	 JJR	O
precision  	precision  	 NN	O
than  	than  	 IN	O
echocardiography  	echocardiography  	 NN	B-NP
but  	but  	 CC	O
is  	is  	 VBZ	O
unable  	unable  	 JJ	O
to  	to  	 TO	O
assess  	assess  	 VB	O
diastolic  	diastolic  	 JJ	B-NP
function  	function  	 NN	I-NP
and  	and  	 CC	O
is  	is  	 VBZ	O
not  	not  	 RB	O
as  	as  	 RB	O
widely  	widely  	 RB	O
available 	available 	 JJ	O
.  	.  	 .	O
Where  	Where  	 WRB	O
CMR  	CMR  	 NNP	B-NP
adds  	adds  	 VBZ	O
unique  	unique  	 JJ	O
advantages  	advantages  	 NNS	O
is  	is  	 VBZ	O
in  	in  	 IN	O
evaluating  	evaluating  	 VBG	O
myocardial  	myocardial  	 JJ	B-NP
tissue  	tissue  	 NN	I-NP
characterisation 	characterisation 	 NN	I-NP
.  	.  	 .	O
With  	With  	 IN	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	O
contrast 	contrast 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
latest  	latest  	 JJS	O
type  	type  	 NN	O
of  	of  	 IN	O
late  	late  	 JJ	O
gadolinium  	gadolinium  	 JJ	B-NP
enhancement  	enhancement  	 NN	I-NP
imaging  	imaging  	 NN	I-NP
( 	( 	 -LRB-	O
phase-sensitive  	phase-sensitive  	 JJ	B-NP
inversion  	inversion  	 JJ	I-NP
recovery  	recovery  	 NN	I-NP
sequence 	sequence 	 NN	I-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
highly  	highly  	 RB	O
sensitive  	sensitive  	 JJ	O
and  	and  	 CC	O
specific  	specific  	 JJ	O
with  	with  	 IN	O
images  	images  	 NNS	O
virtually  	virtually  	 RB	O
pathognomonic  	pathognomonic  	 VBN	O
for  	for  	 IN	O
amyloidosis 	amyloidosis 	 NN	B-NP
.  	.  	 .	O
CMR  	CMR  	 NNP	B-NP
is  	is  	 VBZ	O
also  	also  	 RB	O
demonstrating  	demonstrating  	 VBG	O
that  	that  	 IN	O
the  	the  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
structural  	structural  	 JJ	O
and  	and  	 CC	O
functional  	functional  	 JJ	B-NP
changes  	changes  	 NNS	I-NP
in  	in  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
amyloid  	amyloid  	 NN	I-NP
is  	is  	 VBZ	O
broader  	broader  	 JJR	O
than  	than  	 IN	O
traditionally  	traditionally  	 RB	O
thought 	thought 	 VBD	O
.  	.  	 .	O
CMR  	CMR  	 NNP	B-NP
with  	with  	 IN	O
T1  	T1  	 CD	B-NP
mapping 	mapping 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
new  	new  	 JJ	O
CMR  	CMR  	 NNP	B-NP
technique 	technique 	 NN	I-NP
,  	,  	 ,	O
can  	can  	 MD	O
measure  	measure  	 VB	O
the  	the  	 DT	O
amyloid  	amyloid  	 JJ	B-NP
burden  	burden  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
myocyte  	myocyte  	 JJ	B-NP
response  	response  	 NN	I-NP
to  	to  	 TO	O
infiltration  	infiltration  	 VB	B-NP
( 	( 	 -LRB-	O
hypertrophy 	hypertrophy 	 CD	B-NP
/ 	/ 	 CD	I-NP
cell  	cell  	 NN	I-NP
loss 	loss 	 NN	I-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
advantages  	advantages  	 NNS	O
for  	for  	 IN	O
tracking  	tracking  	 VBG	B-NP
change  	change  	 NN	I-NP
( 	( 	 -LRB-	O
e.g.  	e.g.  	 CD	O
the  	the  	 DT	O
wall  	wall  	 NN	O
thickness  	thickness  	 NN	O
can  	can  	 MD	O
stay  	stay  	 VB	O
the  	the  	 DT	O
same  	same  	 JJ	O
but  	but  	 CC	O
the  	the  	 DT	O
composition  	composition  	 NN	O
can  	can  	 MD	O
change 	change 	 VB	O
)  	)  	 -RRB-	O
over  	over  	 IN	O
time  	time  	 NN	O
or  	or  	 CC	O
during  	during  	 IN	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
Such  	Such  	 JJ	O
techniques  	techniques  	 NNS	O
hold  	hold  	 VBP	O
great  	great  	 JJ	O
promise  	promise  	 NN	O
for  	for  	 IN	O
advancing  	advancing  	 VBG	B-NP
drug  	drug  	 NN	I-NP
development  	development  	 NN	I-NP
in  	in  	 IN	O
this  	this  	 DT	O
arena  	arena  	 NN	O
and  	and  	 CC	O
providing  	providing  	 VBG	O
new  	new  	 JJ	O
prognostic  	prognostic  	 JJ	B-NP
insights 	insights 	 NNS	I-NP
.  	.  	 .	O
CMR  	CMR  	 NNP	B-NP
with  	with  	 IN	O
tissue  	tissue  	 NN	B-NP
characterisation  	characterisation  	 NN	I-NP
is  	is  	 VBZ	O
rewriting  	rewriting  	 VBG	O
our  	our  	 PRP$	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
cardiac  	cardiac  	 JJ	B-NP
amyloidosis  	amyloidosis  	 NN	I-NP
and  	and  	 CC	O
may  	may  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
the  	the  	 DT	O
development  	development  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
classification 	classification 	 NN	B-NP
,  	,  	 ,	O
therapies  	therapies  	 NNS	O
and  	and  	 CC	O
prognostic  	prognostic  	 JJ	B-NP
systems 	systems 	 NNS	I-NP
.  	.  	 .	O
